These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25671764)

  • 21. 'Dos and don'ts' in the management of hyponatremia.
    Aylwin S; Burst V; Peri A; Runkle I; Thatcher N
    Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
    Der-Nigoghossian C; Lesch C; Berger K
    Pharmacotherapy; 2017 May; 37(5):528-534. PubMed ID: 28295447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
    Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
    Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.
    Chifu I; Gerstl A; Lengenfelder B; Schmitt D; Nagler N; Fassnacht M; Weismann D
    Eur J Endocrinol; 2021 May; 184(5):647-655. PubMed ID: 33635825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
    Jahangiri A; Wagner J; Tran MT; Miller LM; Tom MW; Kunwar S; Blevins L; Aghi MK
    J Neurosurg; 2013 Dec; 119(6):1478-83. PubMed ID: 23971964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia.
    Vilapurathu JK; Rajarajan S
    J Res Pharm Pract; 2014 Jan; 3(1):34-6. PubMed ID: 24991634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrolytes: Sodium Disorders.
    Braun MM; Mahowald M
    FP Essent; 2017 Aug; 459():11-20. PubMed ID: 28806046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokinetics.
    Palmer BF; Rock AD; Woodward EJ
    Drug Des Devel Ther; 2016; 10():339-51. PubMed ID: 26848258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten pitfalls in the proper management of patients with hyponatremia.
    Filippatos TD; Liamis G; Elisaf MS
    Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.
    Cyr PL; Slawsky KA; Olchanski N; Krasa HB; Goss TF; Zimmer C; Hauptman PJ
    Am J Health Syst Pharm; 2011 Feb; 68(4):328-33. PubMed ID: 21289328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility and safety of tolvaptan in cirrhotic patients with hyponatremia: A prospective cohort study.
    Jia JD; Xie W; Ding HG; Mao H; Guo H; Li Y; Wang X; Wang JF; Lu W; Li CZ; Mao Y; Wang GQ; Gao YQ; Wang B; Zhang Q; Ge Y; Wong VW
    Ann Hepatol; 2017; 16(1):123-132. PubMed ID: 28051801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
    Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis.
    Indirli R; Ferreira de Carvalho J; Cremaschi A; Mantovani B; Sala E; Serban AL; Locatelli M; Bertani G; Carosi G; Fiore G; Tariciotti L; Arosio M; Mantovani G; Ferrante E
    Front Endocrinol (Lausanne); 2021; 12():689887. PubMed ID: 34108941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls].
    Hofmann W; Flägel K; Gosch M
    Z Gerontol Geriatr; 2020 Aug; 53(5):463-472. PubMed ID: 32691149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution.
    Ayus JC; Olivero JJ; Frommer JP
    Am J Med; 1982 Jan; 72(1):43-8. PubMed ID: 7058821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [From hyponatremia to tolvaptan].
    Cernaro V; Santoro D; Lacquaniti A; Montalto G; Buemi M
    G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
    Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
    BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
    Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
    Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.
    Annane D; Decaux G; Smith N;
    Am J Med Sci; 2009 Jan; 337(1):28-36. PubMed ID: 19057376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.